Chemotherapy before surgery improves survival from bladder cancerBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7414.520-b (Published 04 September 2003) Cite this as: BMJ 2003;327:520
- David Spurgeon
Patients who received chemotherapy before surgery for locally advanced bladder cancer lived an average of 31 months longer than patients treated with surgery alone, an 11 year study of 307 patients has shown (New England Journal of Medicine 2003;349:859-66).
The principal investigator, Dr H Barton Grossman, professor of urology at the M D Anderson Cancer Center, University of Texas, Houston, said: “Treatment of this disease varies across the country, but we believe neoadjuvant chemotherapy should be used more frequently to treat patients with locally advanced bladder cancer.” …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial